期刊
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
卷 21, 期 6, 页码 1093-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2007.08.005
关键词
-
资金
- NCI NIH HHS [CA62242, CA107476] Funding Source: Medline
In 1978, die term monoclonal gammopathy of undetermined significance (MGUS) was introduced. MGUS is defined as a serum monoclonal (M) protein less than 3.0 g/dL; less than 10% plasma cells in the bone marrow, if done; little or no M protein in the urine; and absence of lytic bone lesions, anemia, hypercalcemia or renal insufficiency. This article discusses the recognition, prevalence, natural history, and progression of MGUS. Management of the disease is discussed along with its association with other disorders. Information on smoldering multiple myeloma is included.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据